Anthropic Offers Up to $50,000 in Claude Credits for Rare Disease Research

On July 20, 2026, Anthropic opened a themed call for applications within its AI for Science program, focused on rare genetic diseases. Selected researchers will receive up to $50,000 in Claude credits for six months of work.

What participants get

Anthropic is allocating up to $50,000 in Claude credits to each approved project for a period of six months. This is the company's first themed call within the broader AI for Science program, which previously accepted applications across all scientific fields.

The program is split into two tracks: one for scientists conducting basic research, the other for early-stage biotech startups that are accelerating clinical development of drugs for rare diseases.

• Applications open on July 20, 2026
• Grant: up to $50,000 in Claude credits for 6 months
• Two tracks: basic science and early-stage biotech startups
• Scale of the problem: around 400 million people and more than 7,000 rare diseases
• Early partner: the Monarch Initiative consortium

Why rare diseases are hard to study

Collectively, rare diseases are among the most common conditions on the planet: according to Anthropic's estimate, around 400 million people live with one of more than 7,000 such disorders. But each individual disease affects only a small population, which makes it hard for clinicians to build patient registries, identify promising therapeutic targets, and plan clinical trials.

Anthropic points to a second difficulty: isolation. Each rare disease is described by its own unique features (a specific genetic mutation or a set of symptoms) and studied separately from the others, which makes it nearly impossible to spot shared mechanisms across diseases. The company argues that AI can help model these diseases, find patterns across many of them at once, and synthesize findings from a large body of literature.

Why the Monarch Initiative matters

The program's early partner is the Monarch Initiative, an international consortium that works to improve the diagnosis of rare diseases and the discovery of their mechanisms. Monarch develops the Mondo Disease Ontology, a computational system that merges disease definitions from OMIM, Orphanet, ICD, and dozens of other sources, as well as the Monarch Knowledge Graph.

Monarch recently built a new "agent-friendly" library called DisMech: Claude reads clinical cases, genetic variant databases, registry schemas, and raw open data, and flags mechanistic similarities between diseases at a speed that was previously out of reach. The consortium invites Anthropic's grantees to use these resources and to extend them.

"Our goal is to build a community of researchers exploring how AI can change our understanding of rare diseases,"

Anthropic says in its blog.

What this means

Anthropic is moving its AI for Science program from scattered individual projects to themed waves. The company is betting that several teams working on related questions and sharing their findings will move faster than each team would on its own.

Frequently asked questions

How much does each grant provide?

Each approved project receives up to $50,000 in Claude credits for six months. This is not a cash payment but access to Anthropic's API.

Who can apply?

Applications are accepted in two tracks: scientists conducting basic research on the mechanisms of rare diseases, and early-stage biotech startups accelerating clinical development.

What is the AI for Science program?

Anthropic launched AI for Science in spring 2025 to accelerate scientific discovery by giving researchers access to its API. Projects it has already supported include drug repurposing and quantum simulation.